Status
Conditions
About
The incidence rate and mortality of lung infection are high worldwide. It is a common and frequently occurring disease which seriously threatens human health. Severe pneumonia accounts for 18-36% of all pneumonia. Severe pneumonia has caused serious economic and medical burden. Therefore, it is urgent to carry out the real-world cohort study of severe pneumonia. Big data and sample library will provide useful clinical guidance and scientific research reserves for clinicians. Through further research, we can improve the treatment success rate and reduce the mortality.
The purpose of this study is to provide reliable biological samples and related data information for the relevant basic and clinical trials in the field of severe pneumonia by carrying out the construction of special disease cohort database and biological sample holographic database, and to establish a long-term sharing platform for the transformation of research results into clinical practice, improve the prognosis of severe pneumonia,and provide the evidence for improving the diagnosis and treatment of severe pneumonia suitable for China's national conditions.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
● Cannot understand and / or implement the investigation protocol.
1,000 participants in 1 patient group
Loading...
Central trial contact
Jieming Qu, MD,PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal